Korean J Urol.  2014 May;55(5):295-299. 10.4111/kju.2014.55.5.295.

Penile Low-Intensity Shock Wave Therapy: A Promising Novel Modality for Erectile Dysfunction

• Abu-Ghanem Y
• Kitrey ND
• Gruenwald
• Appel B
• Vardi Y

• KMID: 1988405
• DOI: http://doi.org/10.4111/kju.2014.55.5.295

Abstract

Penile extracorporeal low-intensity shock wave therapy (LIST) to the penis has recently emerged as a novel and promising modality in the treatment of erectile dysfunction (ED). LIST has angiogenic properties and stimulates neovascularization. If applied to the corpora cavernosa, LIST can improve penile blood flow and endothelial function. In a series of clinical trials, including randomized double-blind sham-controlled studies, LIST has been shown to have a substantial effect on penile hemodynamics and erectile function in patients with vasculogenic ED. LIST is effective in patients who are responsive to phosphodiesterase 5 inhibitors (PDE5i) and can also convert PDE5i nonresponders to responders. The response to LIST wanes gradually over time, and after 2 years, about half of the patients maintain their function. Extensive research is needed to understand the effect of LIST on erectile tissue, to modify the treatment protocol to maximize its outcomes, and to identify the patients who will benefit the most from this treatment.

Keyword

Erectile dysfunction; Penile; Shockwave treatment; Therapy

MeSH Terms

Clinical Protocols
Erectile Dysfunction*
Hemodynamics
Humans
Male
Penis
Phosphodiesterase 5 Inhibitors
Shock*
Phosphodiesterase 5 Inhibitors

Figure

• 

  FIG. 1 The shock waves are delivered through the applicator covering the corpora cavernosa of the penis along the penile shaft and the crura.

Reference

1. Gruenwald I, Appel B, Kitrey ND, Vardi Y. Shockwave treatment of erectile dysfunction. Ther Adv Urol. 2013; 5:95–99. PMID: 23554844.

2. Vardi Y, Appel B, Jacob G, Massarwi O, Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol. 2010; 58:243–248. PMID: 20451317.

3. Seidl M, Steinbach P, Worle K, Hofstadter F. Induction of stress fibres and intercellular gaps in human vascular endothelium by shock-waves. Ultrasonics. 1994; 32:397–400. PMID: 8079400.

4. Qureshi AA, Ross KM, Ogawa R, Orgill DP. Shock wave therapy in wound healing. Plast Reconstr Surg. 2011; 128:721e–727e.

5. Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM, Dimmeler S. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation. 2006; 114:2823–2830. PMID: 17145991.

6. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation. 2004; 110:3055–3061. PMID: 15520304.

7. Lei H, Liu J, Li H, Wang L, Xu Y, Tian W, et al. Low-intensity shock wave therapy and its application to erectile dysfunction. World J Mens Health. 2013; 31:208–214. PMID: 24459653.

8. Wang CJ, Wang FS, Yang KD, Weng LH, Hsu CC, Huang CS, et al. Shock wave therapy induces neovascularization at the tendon-bone junction: a study in rabbits. J Orthop Res. 2003; 21:984–989. PMID: 14554209.

9. Stojadinovic A, Elster EA, Anam K, Tadaki D, Amare M, Zins S, et al. Angiogenic response to extracorporeal shock wave treatment in murine skin isografts. Angiogenesis. 2008; 11:369–380. PMID: 18998221.

10. Yan X, Zeng B, Chai Y, Luo C, Li X. Improvement of blood flow, expression of nitric oxide, and vascular endothelial growth factor by low-energy shockwave therapy in random-pattern skin flap model. Ann Plast Surg. 2008; 61:646–653. PMID: 19034081.

11. Oi K, Fukumoto Y, Ito K, Uwatoku T, Abe K, Hizume T, et al. Extracorporeal shock wave therapy ameliorates hindlimb ischemia in rabbits. Tohoku J Exp Med. 2008; 214:151–158. PMID: 18285673.

12. Mittermayr R, Antonic V, Hartinger J, Kaufmann H, Redl H, Teot L, et al. Extracorporeal shock wave therapy (ESWT) for wound healing: technology, mechanisms, and clinical efficacy. Wound Repair Regen. 2012; 20:456–465. PMID: 22642362.

13. Gruenwald I, Appel B, Vardi Y. Low-intensity extracorporeal shock wave therapy: a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. J Sex Med. 2012; 9:259–264. PMID: 22008059.

14. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003; 348:593–600. PMID: 12584367.

15. Uwatoku T, Ito K, Abe K, Oi K, Hizume T, Sunagawa K, et al. Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs. Coron Artery Dis. 2007; 18:397–404. PMID: 17627190.

16. Ito Y, Ito K, Shiroto T, Tsuburaya R, Yi GJ, Takeda M, et al. Cardiac shock wave therapy ameliorates left ventricular remodeling after myocardial ischemia-reperfusion injury in pigs in vivo. Coron Artery Dis. 2010; 21:304–311. PMID: 20617568.

17. Kikuchi Y, Ito K, Ito Y, Shiroto T, Tsuburaya R, Aizawa K, et al. Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris. Circ J. 2010; 74:589–591. PMID: 20134096.

18. Yang P, Guo T, Wang W, Peng YZ, Wang Y, Zhou P, et al. Randomized and double-blind controlled clinical trial of extracorporeal cardiac shock wave therapy for coronary heart disease. Heart Vessels. 2013; 28:284–291. PMID: 22457097.

19. Vasyuk YA, Hadzegova AB, Shkolnik EL, Kopeleva MV, Krikunova OV, Iouchtchouk EN, et al. Initial clinical experience with extracorporeal shock wave therapy in treatment of ischemic heart failure. Congest Heart Fail. 2010; 16:226–230. PMID: 20887620.

20. Wang Y, Guo T, Ma TK, Cai HY, Tao SM, Peng YZ, et al. A modified regimen of extracorporeal cardiac shock wave therapy for treatment of coronary artery disease. Cardiovasc Ultrasound. 2012; 10:35. PMID: 22898340.

21. Saggini R, Figus A, Troccola A, Cocco V, Saggini A, Scuderi N. Extracorporeal shock wave therapy for management of chronic ulcers in the lower extremities. Ultrasound Med Biol. 2008; 34:1261–1271. PMID: 18394777.

22. Larking AM, Duport S, Clinton M, Hardy M, Andrews K. Randomized control of extracorporeal shock wave therapy versus placebo for chronic decubitus ulceration. Clin Rehabil. 2010; 24:222–229. PMID: 20156981.

23. Chen KK, Chang LS. The effect of extracorporeal shock wave on cavernous nerve stimulation-induced intracavernous pressure increase in the rat [abstract 816]. J Urol. 2013; 189:e335.

24. Liu J, Li GY, Zhou F, Wang L, Li HX, Xin ZC. Efficacy and possible mechanism of extracorporeal shock wave therapy on streptozotocin induced diabetic erectile dysfunction rats model [abstract 1028]. J Urol. 2013; 189:e421.

25. Qiu X, Lin G, Xin Z, Ferretti L, Zhang H, Lue TF, et al. Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model. J Sex Med. 2013; 10:738–746. PMID: 23253086.

26. Chen YJ, Wurtz T, Wang CJ, Kuo YR, Yang KD, Huang HC, et al. Recruitment of mesenchymal stem cells and expression of TGF-beta 1 and VEGF in the early stage of shock wave-promoted bone regeneration of segmental defect in rats. J Orthop Res. 2004; 22:526–534. PMID: 15099631.

27. Vardi Y, Appel B, Kilchevsky A, Gruenwald I. Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J Urol. 2012; 187:1769–1775. PMID: 22425129.

28. Gruenwald I, Kitrey ND, Appel B, Vardi Y. Low-intensity extracorporeal shock wave therapy in vascular disease and erectile dysfunction: theory and outcomes. Sex Med Rev. 2013; 1:83–90.

29. Vardi Y, Appel B, Kitrey ND, Massarwa O, Gruenwald I. Low-intensity shockwave treatment for ED - long term follow up of 2 years [abstract]. In : The 29th European Association of Urology Annual Congress; 2014 Apr 11-14; Stockholm, Sweden. Arnhem: European Association of Urology;2014.

30. Vardi Y, Appel B, Kitrey ND, Massarwa O, Gruenwald I. Additional shockwave treatment improves erectile function in patients with poor response to the standard shockwave protocol [abstract]. In : The 29th European Association of Urology Annual Congress; 2014 Apr 11-14; Stockholm, Sweden. Arnhem: European Association of Urology;2014.

31. Reisman Y, Hind A, Varaneckas A, Motil I. Efficacy and Safety of Linear Focused Shockwaves for Erectile Dysfunction (RENOVA) - A Second Generation Technolog [abstract]. In : The 12th congress of the Latin American Society for Sexual Medicine; 2013 Aug 28-31; Cancun, Mexico. Latin American Society for Sexual Medicine;2013.

32. Lacono F. Low intensity shock wave (LISW) treatment (Renova) in order to improve male sexual function: a preliminary data on 42 patients [abstract]. In : The 16th Congress of the European Society for Sexual Medicine; 2014 Jan 29-Feb. 1; Istanbul, Turkey. European Society for Sexual Medicine;2014.

33. Lund L. Treatment of erectile dysfunction with extracorporeal shockwave therapy (ESWT). A prospective, randomised, double-blind, placebo-controlled study [abstract]. In : The 16th Congress of the European Society for Sexual Medicine; 2014 Jan 29-Feb. 1; Istanbul, Turkey. European Society for Sexual Medicine;2014.